US-based packaging firm Silgan Holdings is contemplating a potential acquisition of German medical packaging producer Gerresheimer, reported Reuters.
Sources point out that Silgan is working with advisers on a proposal that will worth Gerresheimer at €41 ($47.22) per share.
Nonetheless, they emphasised that it isn’t but sure whether or not a proper bid will probably be made or if any deal will probably be finalised.
Gerresheimer declined to reply when requested for remark, and Silgan didn’t present a right away response.
Gerresheimer has confronted important challenges in current months.
The corporate’s market capitalisation at present stands at €600m ($694m), with its share worth having dropped greater than 80% from its highs in 2023 and falling by 37% because the starting of this 12 months.
Late final month, Gerresheimer introduced that Germany’s monetary regulator BaFin was increasing its examination of the corporate’s monetary statements.
This improvement comes because the enterprise continues to deal with accounting points and falling share values.
Discussions between Gerresheimer and personal fairness buyers a couple of potential sale occurred final 12 months however concluded with out settlement.
For the fourth quarter of 2025, Silgan reported web earnings of $18.2m, down from $45.1m in the identical interval of 2024.
Its full-year web earnings for 2025 rose to $288.4m from $276.4m in 2024.
Silgan has projected adjusted web earnings per diluted share to vary from $3.7 to $3.9 for 2026, a modest rise from its midpoint adjusted determine of $3.72 for 2025.
Within the earlier 12 months, Silgan accomplished its acquisition of Weener Plastics, a Dutch allotting options supplier for the private care, meals, and healthcare industries, in a transaction valued at €838m ($908m).
“Silgan weighs bid for Gerresheimer – report” was initially created and printed by Packaging Gateway, a GlobalData owned model.
The data on this website has been included in good religion for normal informational functions solely. It’s not supposed to quantity to recommendation on which you need to rely, and we give no illustration, guarantee or assure, whether or not specific or implied as to its accuracy or completeness. You need to receive skilled or specialist recommendation earlier than taking, or refraining from, any motion on the idea of the content material on our website.
